Hormones and dry eye disease

Area of Science:

• Endocrinology
• Ophthalmology
• Cell Biology

Background:

• The endocrine system regulates bodily functions, and its hormones interact with ocular surface receptors.
• Dry eye disease (DED) is a complex condition influenced by various factors, including endocrine anomalies.
• Hormonal fluctuations and dysregulation are increasingly recognized as key contributors to DED pathogenesis.

Purpose of the Study:

• To review the role of endocrine system anomalies in the etiology and progression of dry eye disease.
• To elucidate the mechanisms by which hormones affect ocular surface structures and contribute to DED.
• To discuss the clinical implications and therapeutic potential of hormonal interventions in DED management.

Main Methods:

• Literature review of studies investigating the endocrine system's influence on ocular surface health.
• Analysis of hormonal mechanisms affecting ocular tissues in conditions like menopause, PCOS, and diabetes.
• Examination of clinical data on hormone replacement therapy, insulin therapeutics, and thyroid hormone effects in DED.

Main Results:

• Androgens, estrogens, and progesterone significantly impact ocular surface tissues; androgen deficiency is linked to DED.
• Menopause and associated hormone changes, as well as insulin resistance, are implicated in DED development.
• Thyroid hormones and insulin show complex effects on the ocular surface, with potential therapeutic applications.

Conclusions:

• Endocrine anomalies are significant inciting factors in dry eye disease.
• A comprehensive understanding of hormonal influences on the ocular surface is vital for DED diagnosis and treatment.
• Hormonal therapeutics hold promise for managing DED, necessitating consideration of endocrine status in patient care.